Lupin Lisinopril Tablets Recall: Foreign Metal Piece in Some Tablets
Lupin Pharmaceuticals recalls 10 mg Lisinopril tablets with a metal piece embedded in one tablet. This could cause injury if swallowed. Consumers should contact the company for details.
Lower-risk recall
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Contact the company
What happened, in plain English
Lupin Pharmaceuticals is recalling 10 mg Lisinopril tablets that may contain a metal piece. This foreign material could cause injury if swallowed, so affected consumers should stop using the tablets and contact the company. Read more at govinfonow.com/recall/34328-lupin-lisinopril-tablets-recall-foreign-metal-piece-in-some-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/34328-lupin-lisinopril-tablets-recall-foreign-metal-piece-in-some-tablets · Updated August 18, 2026 · FDA enforcement record: FDA #D-1536-2022
Cite this page
“Lupin Lisinopril Tablets Recall: Foreign Metal Piece in Some Tablets.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34328-lupin-lisinopril-tablets-recall-foreign-metal-piece-in-some-tablets. Based on FDA recall #D-1536-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1536-2022%22&limit=1).
Why it’s dangerous
A small metal piece is embedded in one tablet. If swallowed, it could cause injury or internal damage. This is a foreign object hazard.
Who’s affected
People who have the 1000-count bottles of Lisinopril 10 mg tablets, Rx Only, manufactured by Lupin Pharmaceuticals Inc. in Baltimore, Maryland. Those taking blood pressure medication are most at risk.
How to tell if you have this one
Check for the product name 'Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only'. The lot number is Q201182 with an expiration date of March 2024.
- Brand
Lupin Pharmaceuticals- Category
Drug
What to do — step by step
Stop Using Tablets
If you have the recalled 1000-count bottles of Lisinopril 10 mg tablets, stop using them immediately.
Contact Company
Contact Lupin Pharmaceuticals for instructions on how to return the tablets or get a replacement.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Product was distributed to major distributors/wholesalers nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Lupin Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1536-2022 (September 13, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1536-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.